Novel Combination Of Lenalidomide-Rituximab Provides An Effective Bridge To Stem Cell Transplantation In Relapsed and/Or Refractory Aggressive B-Cell Non-Hodgkin's Lymphomas: A Single Center Experience

被引：0
|
作者：
Cai, Qingqing
Chen, Yiming
Zou, Dehui
Badillo, Maria
Zhou, Shouhao
Zhang, Liang
Lopez, Elyse R.
Jiang, Wenqi
Huang, Hui-qiang
Lin, Tongyu
Wang, Michael
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.3056.3056
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3056
引用
收藏
页数：2
相关论文
共 50 条
  • [31] High response rate to lenalidomide in relapsed/refractory aggressive non-Hodgkin's lymphoma with prior stem cell transplant
    Vose, Julie M.
    Tuscano, Joseph M.
    Justice, Glen
    Lossos, Izidore S.
    Ervin-Haynes, Annette
    Takeshita, Kenichi
    Pietronigro, Dennis
    Zeldis, Jerome B.
    Habermann, Thomas M.
    BLOOD, 2007, 110 (11) : 757A - 758A
  • [32] Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma
    Dang, Nam H.
    Fayad, Luis
    McLaughlin, Peter
    Romaguara, Jorge E.
    Hagemeister, Fredrick
    Goy, Andre
    Neelapu, Sattva
    Samaniego, Felipe
    Walker, Pamela L.
    Wang, Michael
    Rodriguez, Maria A.
    Tong, Ann T.
    Pro, Barbara
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (04) : 502 - 505
  • [33] RITUXIMAB IN THERAPY OF PERIPHERAL B-CELL NON-HODGKIN'S LYMPHOMAS IN CHILDREN
    Valiev, T. T.
    Morozova, O. V.
    Makhonova, L. A.
    Mentkevich, G. L.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2010, 55 (03): : 13 - 16
  • [34] Rituximab Combined with BEAM and Autologous Stem Cell Transplantation for Older Patients with Relapsed Aggressive B-Cell Lymphomas
    Srour, Samer A.
    Khouri, Issa F.
    Lozano-Cerrada, Sara
    Nieto, Yago
    Alousi, Amin M.
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Anderlini, Paolo
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Hosing, Chitra
    BLOOD, 2016, 128 (22)
  • [35] Efficacy and safety of rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
    Harting, Rekha
    Venugopal, Pararneswaran
    Gregory, Stephanie A.
    O'Brien, Teresa
    Bogdanova, Elena
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (06): : 406 - 412
  • [36] Targeting Aurora Kinase in Aggressive B-Cell Non-Hodgkin's Lymphomas
    Mahadevan, Daruka
    Qi, Wenqing
    Cooke, Laurence
    Lui, Xiabing
    Persky, Daniel Oscar
    Rimsza, Lisa M.
    Miller, Thomas P.
    BLOOD, 2009, 114 (22) : 120 - 120
  • [37] Allogeneic Stem Cell Transplantation for Patients with Chemo-Refractory or Progressive Aggressive Non-Hodgkin's Lymphomas
    Hamadani, Mehdi
    Blum, Kristie A.
    Elder, Patrick
    Lin, Thomas S.
    Porcu, Pierluigi
    Hofmeister, Craig C.
    Blum, William
    Marcucci, Guido
    Benson, Don
    Devine, Steven
    BLOOD, 2008, 112 (11) : 1121 - 1121
  • [38] Autologous stem cell transplantation for relapsed/refractory Hodgkin's lymphoma: a single-center experience
    Genadieva-Stavrik, S.
    Pivkova-Veljanovska, A.
    Stojanoski, Z.
    Krstevska-Balkanov, S.
    Karanfilski, O.
    Cadievski, L.
    Georgievski, B.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S445 - S445
  • [39] A Phase I Study of Ibrutinib and Lenalidomide in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma
    Christian, Beth
    Kuruvilla, John
    Smith, Sonali
    Porcu, Pierluigi
    Ruppert, Amy S.
    Byrd, John C.
    Grever, Michael R.
    Blum, Kristie A.
    BLOOD, 2014, 124 (21)
  • [40] Autologous peripheral blood stem cell transplant for relapsed or refractory T-cell non-Hodgkin's lymphoma results in inferior long term survival when compared to relapsed or refractory B-cell non-Hodgkin's lymphomas
    Hsu, JW
    Singh, P
    Goldberg, SL
    Pecora, AL
    Siegel, DS
    Rowley, SD
    BLOOD, 2004, 104 (11) : 395B - 396B
12345